OUD Archives - Page 2 of 5

New in SAj: Predictors of substance use disorder treatment initiation and engagement among adolescents enrolled in Medicaid

Jul 8, 2022 by AMERSA

Adolescents with substance use disorders (SUD) should receive timely access to treatment to improve lifelong outcomes. The Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment (IET) performance measure was intended to promote quality improvement for patients with SUD. Yet, few studies have assessed predictors of measure performance among adolescents or other engagement in mental health services, which is critical to understanding disparities in treatment quality or opportunities for targeted improvement strategies. The present study reports the rates and predictors of IET among adolescents with SUD, as well as receipt of any mental health services.

This article comes from authors Laura J. Chavez, PhD, MPH,Danielle L. Steelesmith , PhD,Jeffrey A. Bridge, PhD, and Cynthia A. Fontanella, PhD and was published in SAj on June 3, 2022.

Read it now!

New in SAj: Differences in the delivery of medications for opioid use disorder during hospitalization by racial categories: A retrospective cohort analysis

Jun 29, 2022 by AMERSA

This study assessed differences in the delivery of buprenorphine versus methadone during acute medical or surgical hospitalizations for veterans with opioid use disorder (OUD) by racial categories (Black Non-Hispanic or Latino vs. White Non-Hispanic or Latino).

Kelsey C. Priest, MD PhD MPH, Caroline A. King, PhD MPH, Honora Englander, MD, Travis I. Lovejoy, PhD MPH and Dennis McCarty, PhD found that differences in hospital-based MOUD delivery may be influenced by MOUD received prior to hospitalization within the racialized outpatient addiction treatment system.

This original research article was just published in SAj Volume 43, Issue 1 on June 7, 2022. Read it now!

New in SAj: Perceptions of prescription opioid use among rural farming and ranching communities: Preliminary implications for outreach and treatment

Jun 27, 2022 by AMERSA

The purpose of this study was to explore the prevalence and perceptions related to prescription opioids among rural producers and farmworkers. Authors, Kristine Ramsay-Seaner, PhD, Amber Letcher, PhD, Meagan Scott Hoffman, PhD, Emily Anderson, MA and Charlotte Heckmann, BS, found that outreach efforts that increase access to healthcare services and alternative pain management treatments for agricultural workers may mitigate the experience of chronic pain that can interfere with their overall quality of life.

You can find this article in SAj Volume 43, Issue 1 or you can read it here.

New in SAj: Cannabis and cocaine use, drinking outcomes, and quality of life in general hospital inpatients with alcohol use disorder

Jun 23, 2022 by AMERSA

Esperanza Romero-Rodríguez, MD MSc PhD, Clara A. Chen, MHS, Kimberly A. Dukes, PhD, Kaitlin Hartlage, MPH, Tibor P. Palfai, PhD, Kara M. Magane, MS, Jeffrey H. Samet, MD MA MPH and Richard Saitz, MD MPH assess associations between cannabis and cocaine use and two outcomes [heavy drinking days and quality of life] among hospital inpatients with an alcohol use disorder.

This brief report was just published in SAj Volume 43, Issue 1 on June 7, 2022. Read it now!

New in SAj: Who benefits from Two Way Prayer Meditation? Treatment effect moderators in a pilot randomized controlled trial of a spiritual intervention for people with substance use disorders

Feb 7, 2022 by AMERSA

“Who benefits from Two Way Prayer Meditation? Treatment effect moderators in a pilot randomized controlled trial of a spiritual intervention for people with substance use disorders” was published in the Substance Abuse Journal (SAj) today, February 7, 2022 from Audrey Hang Hai, PhD, Bill Wigmore, BA, Cynthia Franklin, PhD, Clayton Shorkey, PhD, Kirk von Sternberg, PhD, Allan Hugh Cole Jr., PhD, and Diana M. DiNitto, PhD.

This study aimed to identify moderators of two way prayer meditation (TWPM) treatment effects. Moderators tested included gender, race/ethnicity, age, education, religious/spiritual affiliation, and most often used substance. Methods: This study employed a randomized controlled trial design with pretest and posttest. In total, 134 adults in four residential recovery programs participated in the study and were randomly assigned to the TWPM group or the treatment as usual control group.

Read this article now! and follow us on twitter to stay up to date with new publications!